Table 2.
The crude incidence rate of hyperuricemia categorised by the tertiles of TyG and its derivatives.
| Person-years | Incident HUA | Crude incidence rate | |
|---|---|---|---|
| Total | 138,163 | 4,230 | 30.6 |
| TyG | |||
| T1 | 46,690 | 710 | 15.2 |
| T2 | 45,782 | 1,314 | 28.7 |
| T3 | 45,691 | 2,206 | 48.3 |
| TyG-BMI | |||
| T1 | 46,247 | 654 | 14.1 |
| T2 | 46,147 | 1,272 | 27.6 |
| T3 | 45,769 | 2,304 | 50.3 |
| TyG-WC | |||
| T1 | 46,280 | 568 | 12.3 |
| T2 | 46,043 | 1,309 | 28.4 |
| T3 | 45,840 | 2,353 | 51.3 |
| TyG-WHtR | |||
| T1 | 46,162 | 688 | 14.9 |
| T2 | 46,100 | 1,307 | 28.4 |
| T3 | 45,901 | 2,235 | 48.7 |
HUA, hyperuricemia; T, tertile; TG, triglyceride; FPG, fasting plasma glucose; TyG, triglyceride and glucose index; BMI, body mass index; WC, waist circumference; WHtR, waist-to-height ratio; the crude incident rate is expressed per 1000 person-years.